Xenotransplantation: An overview of the field

Methods in Molecular Biology

Volumn 885, Issue , 2012, Pages 1-16

  Tisato, Veronica ^a,b,c   Cozzi, Emanuele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CORIT ^*  (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Acute humoral xenograft rejection; Cellular rejection; Cellular transplantation; Hyperacute rejection; Molecular incompatibility; Tolerance; Transgenic animals; Xenotransplantation; Zoonoses

Indexed keywords

ANIMAL; CELL TRANSPLANTATION; ETHICS; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; METHODOLOGY; ORGAN TRANSPLANTATION; REVIEW; XENOGRAFT;

ANIMALS; CELL TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; ORGAN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA;

EID: 84864124172     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-845-0_1     Document Type: Review

References (98)

1. http://www.unos.org
2. http://www.edqm.eu
3. Leor J, Aboula fi a-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S (2000) Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102:III56-III61
4. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223-230
5. Shimizu T, Sekine H, Yamato M, Okano T (2009) Cell sheet-based myocardial tissue engineering: New hope for damaged heart rescue. Curr Pharm Des 15:2807-2814
6. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA (2008) Perfusion-decellularized matrix: Using nature's platform to engineer a bioarti fi cial heart. Nat Med 14:213-221
7. Ross EA, Williams MJ, Hamazaki T, Terada N, Clapp WL, Adin C, Ellison GW, Jorgensen M, Batich CD (2009) Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 20: 2338-2347
8. Baptista PM, Orlando G, Mirmalek-Sani SH, Siddiqui M, Atala A, Soker S (2009) Whole organ decellularization-a tool for biosca ffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc 2009: 6526-6529
9. Nakayama KH, Batchelder CA, Lee CI, Tarantal AF (2010) Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A 16:2207-2216
10. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, Milwid J, Kobayashi N, Tilles A, Berthiaume F, Hertl M, Nahmias Y, Yarmush ML, Uygun K (2010) Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16:814-820
11. Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L, Kotton D, Vacanti JP (2010) Regeneration and orthotopic transplantation of a bioarti fi cial lung. Nat Med 16:927-933
12. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, Gavrilov K, Yi T, Zhuang ZW, Breuer C, Herzog E, Niklason LE (2010) Tissue-engineered lungs for in vivo implantation. Science 329:538-541
13. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF (1993) Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA 90:11391-11395
14. Schuurman HJ, Cheng J, Lam T (2003) Pathology of xenograft rejection: A commentary. Xenotransplantation 10:293-299
15. Platt JL (2000) Acute vascular rejection. Transplant Proc 32:839-840
16. McGregor CGA, Keiji Oi WRD, Tazelaar HD, Walker RC, Chandrasekaran K, Byrne GW (2008) Recovery of cardiac function after pigto-primate orthotopic heart transplant. Am J Transplant 8(Suppl s2):205
17. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, Greenstein JL, Hawley RJ, Patience C, Awwad M, Fishman JA, Robson SC, Schuurman HJ, Sachs DH, Cooper DK (2005) Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 11:29-31
18. Tseng YL, Kuwaki K, Dor FJ, Shimizu A, Houser S, Hisashi Y, Yamada K, Robson SC, Awwad M, Schuurman HJ, Sachs DH, Cooper DK (2005) alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80:1493-1500
19. Baldan N, Rigotti P, Calabrese F, Cadrobbi R, Dedja A, Iacopetti I, Boldrin M, Seveso M, Dall'Olmo L, Frison L, De Benedictis G, Bernardini D, Thiene G, Cozzi E, Ancona E (2004) Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: A phenomenon related to immunological events? Am J Transplant 4:475-481
20. Shimizu A, Hisashi Y, Kuwaki K, Tseng YL, Dor FJ, Houser SL, Robson SC, Schuurman HJ, Cooper DK, Sachs DH, Yamada K, Colvin RB (2008) Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 172:1471-1481
21. Lin CC, Ezzelarab M, Shapiro R, Ekser B, Long C, Hara H, Echeverri G, Torres C, Watanabe H, Ayares D, Dorling A, Cooper DK (2010) Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 10:1556-1568
22. Sullivan JA, Oettinger HF, Sachs DH, Edge AS (1997) Analysis of polymorphism in porcine MHC class I genes: Alterations in signals re cognized by human cytotoxic lymphocytes. J Immunol 159:2318-2326
23. Forte P, Lilienfeld BG, Baumann BC, Seebach JD (2005) Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 175:5463-5470
24. Schneider MK, Seebach JD (2008) Current cellular innate immune hurdles in pig-to-primate xenotransplantation. Curr Opin Organ Transplant 13:171-177
25. Goto M, Tjernberg J, Dufrane D, Elgue G, Brandhorst D, Ekdahl KN, Brandhorst H, Wennberg L, Kurokawa Y, Satomi S, Lambris JD, Gianello P, Korsgren O, Nilsson B (2008) Dissecting the instant blood-mediated in fl ammatory reaction in islet xenotransplantation. Xenotransplantation 15:225-234
26. Van Der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK (2007) Rapid loss of intraportally transplanted islets: An overview of pathophysiology and preventive strategies. Xenotransplantation 14:288-297
27. Hering BJ, Walawalkar N (2009) Pig-tononhuman primate islet xenotransplantation. Transpl Immunol 21:81-86
28. Dufrane D, Goebbels RM, Gianello P (2010) Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months with out immunosuppression. Transplantation 90:1054-1062
29. Komoda H, Miyagawa S, Kubo T, Kitano E, Kitamura H, Omori T, Ito T, Matsuda H, Shirakura R (2004) A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 11:237-246
30. Bennet W, Bjorkland A, Sundberg B, Davies H, Liu J, Holgersson J, Korsgren O (2000) A comparison of fetal and adult porcine islets with regard to Gal alpha (1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity. Transplantation 69:1711-1717
31. Rayat GR, Rajotte RV, Hering BJ, Binette TM, Korbutt GS (2003) In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol 177:127-135
32. Rayat GR, Rajotte RV, Elliott JF, Korbutt GS (1998) Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes 47:1406-1411
33. Schulte Am Esch J 2nd, Robson SC, Knoefel WT, Hosch SB, Rogiers X (2005) O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 12:30-37
34. Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d'Apice AJ, Cowan PJ (2008) Am Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 8: 1101-1112
35. Kopp CW, Siegel JB, Hancock WW, Anrather J, Winkler H, Geczy CL, Kaczmarek E, Bach FH, Robson SC (1997) Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 63:749-758
36. Kopp CW, Robson SC, Siegel JB, Anrather J, Winkler H, Grey S, Kaczmarek E, Bach FH, Geczy CL (1998) Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells. Thromb Haemost 79: 529-538
37. Lee KF, Salvaris EJ, Roussel JC, Robson SC, d'Apice AJ, Cowan PJ (2008) Recombinant pig TFPI ef fi ciently regulates human tissue factor pathways. Xenotransplantation 15: 191-197
38. Lin CC, Ezzelarab M, Hara H, Long C, Lin CW, Dorling A, Cooper DK (2010) Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells. J Thromb Haemost 8:2001-2010
39. Lee H, Lee B, Kim Y, Paik N, Rho H (2011) Characterization of transgenic pigs that express human decay accelerating factor and cell membrane-tethered human tissue factor pathway inhibitor. Reprod Domest Anim 46:325-332
40. Chen D, Riesbeck K, Kemball-Cook G, McVey JH, Tuddenham EG, Lechler RI, Dorling A (1999) Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins. Transplantation 67:467-474
41. Miwa Y, Yamamoto K, Onishi A, Iwamoto M, Yazaki S, Haneda M, Iwasaki K, Liu D, Ogawa H, Nagasaka T, Uchida K, Nakao A, Kadomatsu K, Kobayashi T (2010) Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation 17:26-37
42. Crikis S, Lu B, Murray-Segal LM, Selan C, Robson SC, D'Apice AJ, Nandurkar HH, Cowan PJ, Dwyer KM (2010) Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant 10:2586-2595
43. Dwyer KM, Robson SC, Nandurkar HH, Campbell DJ, Gock H, Murray-Segal LJ, Fisicaro N, Mysore TB, Kaczmarek E, Cowan PJ, d'Apice AJ (2004) Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113: 1440-1446
44. Cowan PJ, Robson SC, D'Apice AJ (2011) Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 16:214-221
45. Lin CC, Cooper DK, Dorling A (2009) Coagulation dysregulation as a barrier to xenotransplantation in the primate. Transpl Immunol 21:75-80
46. Vial CM, Ostlie DJ, Bhatti FN, Cozzi E, Goddard M, Chavez GP, Wallwork J, White DJ, Dunning JJ (2000) Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 19:224-229
47. Soin B, Smith KG, Zaidi A, Cozzi E, Bradley JR, Ostlie DJ, Lockhart A, White DJ, Friend PJ (2001) Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 60:1592-1597
48. Van Der Windt DJ, Bottino R, Casu A, Campanile N, Smetanka C, He J, Murase N, Hara H, Ball S, Loveland BE, Ayares D, Lakkis FG, Cooper DK, Trucco M (2009) Long-term controlled normoglycemia in diabetic nonhuman primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 9:2716-2726
49. Daggett CW, Yeatman M, Lodge AJ, Chen EP, Linn SS, Gullotto C, Frank MM, Platt JL, Davis RD (1998) Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 115:19-27
50. Cooper DK, Keogh AM, Brink J, Corris PA, Klepetko W, Pierson RN, Schmoeckel M, Shirakura R, Warner Stevenson L (2000) Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: The present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 19:1125-1165
51. Pfeiffer S, Zorn GL 3rd, Blair KS, Farley SM, Wu G, Schuurman HJ, White DJ, Azimzadeh AM, Pierson RN 3rd (2005) Hyperacute lung rejection in the pig-to-human model 4: Evidence for complement and antibody independent mechanisms. Transplantation 79:662-671
52. Ibrahim Z, Busch J, Awwad M, Wagner R, Wells K, Cooper DK (2006) Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 13:488-499
53. Ramirez P, Chavez R, Majado M, Munitiz V, Munoz A, Hernandez Q, Palenciano CG, Pino-Chavez G, Loba M, Minguela A, Yelamos J, Gago MR, Vizcaino AS, Asensi H, Cayuela MG, Segura B, Marin F, Rubio A, Fuente T, Robles R, Bueno FS, Sansano T, Acosta F, Rodriguez JM, Navarro F, Cabezuelo J, Cozzi E, White DJ, Calne RY, Parrilla P (2000) Lifesupporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 70:989-998
54. Ramirez P, Montoya MJ, Rios A, Garcia Palenciano C, Majado M, Chavez R, Munoz A, Fernandez OM, Sanchez A, Segura B, Sansano T, Acosta F, Robles R, Sanchez F, Fuente T, Cascales P, Gonzalez F, Ruiz D, Martinez L, Pons JA, Rodriguez JI, Yelamos J, Cowan P, d'Apice A, Parrilla P (2005) Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant Proc 37:4103-4106
55. Ekser B, Gridelli B, Tector AJ, Cooper DK (2009) Pig liver xenotransplantation as a bridge to allotransplantation: Which patients might bene fi t? Transplantation 88:1041-1049
56. Swindle MM (1998) De fi ning appropriate health status and management programs for speci fi c-pathogen-free swine for xenotransplantation. Ann N Y Acad Sci 862:111-120
57. Clemenceau B, Lalain S, Martignat L, Sai P (1999) Porcine endogenous retroviral mRNAs in pancreas and a panel of tissues from specific pathogen-free pigs. Diabetes Metab 25: 518-525
58. Patience C, Takeuchi Y, Weiss RA (1997) Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282-286
59. Martin U, Kiessig V, Blusch JH, Haverich A, von Der Helm K, Herden T, Steinhoff G (1998) Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 352:692-694
60. Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, Takeuchi Y (2004) Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 78:13880-13890
61. Meije Y, Tonjes RR, Fishman JA (2010) Retroviral restriction factors and infectious risk in xenotransplantation. Am J Transplant 10: 1511-1516
62. Valdes-Gonzalez R, Dorantes LM, Bracho-Blanchet E, Rodriguez-Ventura A, White DJ (2010) No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long-term porcine islet xenotransplantation. J Med Virol 82:331-334
63. Di Nicuolo G, D'Alessandro A, Andria B, Scuderi V, Scognamiglio M, Tammaro A, Mancini A, Cozzolino S, Di Florio E, Bracco A, Calise F, Chamuleau RA (2010) Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cellbased Academic Medical Center bioarti fi cial liver. Xenotransplantation 17:431-439
64. Mueller NJ, Barth RN, Yamamoto S, Kitamura H, Patience C, Yamada K, Cooper DK, Sachs DH, Kaur A, Fishman JA (2002) Activation of cytomegalovirus in pig-to-primate organ xenotransplantation. J Virol 76:4734-4740
65. Ehlers B, Ulrich S, Goltz M (1999) Detection of two novel porcine herpesviruses with high similarity to gammaherpesviruses. J Gen Virol 80(Pt 4):971-978
66. Santoni F, Lindner I, Caselli E, Goltz M, Di Luca D, Ehlers B (2006) Molecular interactions between porcine and human gammaherpesviruses: Implications for xenografts? Xenotransplantation 13:308-317
67. Oldmixon BA, Wood JC, Ericsson TA, Wilson CA, White-Scharf ME, Andersson G, Greenstein JL, Schuurman HJ, Patience C (2002) Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 76:3045-3048
68. Mattiuzzo G, Ivol S, Takeuchi Y (2010) Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J Virol 84:2618-2622
69. Ramsoondar J, Vaught T, Ball S, Mendicino M, Monahan J, Jobst P, Vance A, Duncan J, Wells K, Ayares D (2009) Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 16:164-180
70. Dieckhoff B, Petersen B, Kues WA, Kurth R, Niemann H, Denner J (2008) Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 15:36-45
71. Miyagawa S, Nakatsu S, Hazama K, Nakagawa T, Kondo A, Matsunami K, Yamamoto A, Yamada J, Miyazawa T, Shirakura R (2006) A novel strategy for preventing PERV transmission to human cells by remodeling the viral envelope glycoprotein. Xenotransplantation 13:258-263
72. Ekser B, Long C, Echeverri GJ, Hara H, Ezzelarab M, Lin CC, De Vera ME, Wagner R, Klein E, Wolf RF, Ayares D, Cooper DK, Gridelli B (2010) Impact of thrombocytopenia on survival of baboons with genetically modi fi ed pig liver transplants: Clinical relevance. Am J Transplant 10:273-285
73. Gaca JG, Lesher A, Aksoy O, Gonzalez-Stawinski GV, Platt JL, Lawson JH, Parker W, Davis RD (2002) Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 73:1717-1723
74. Gonzalez-Stawinski GV, Daggett CW, Lau CL, Karoor S, Love SD, Logan JS, Gaca JG, Parker W, Davis RD Jr (2002) Non-anti-Gal alpha1-3Gal antibody mechanisms are suf ficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. J Am Coll Surg 194:765-773
75. Nguyen BH, Zwets E, Schroeder C, Pierson RN 3rd, Azimzadeh AM (2005) Beyond antibody-mediated rejection: Hyperacute lung rejection as a paradigm for dysregulated in fl ammation. Curr Drug Targets Cardiovasc Haematol Disord 5:255-269
76. Nguyen BN, Azimzadeh AM, Zhang T, Wu G, Schuurman HJ, Sachs DH, Ayares D, Allan JS, Pierson RN 3rd (2007) Life-supporting function of genetically modi fi ed swine lungs in baboons. J Thorac Cardiovasc Surg 133: 1354-1363
77. Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, Weber CJ, Pearson TC, Rajotte RV, Larsen CP (2006) Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12:304-306
78. Hering BJ, Wijkstrom M, Graham ML, Hardstedt M, Aasheim TC, Jie T, Ansite JD, Nakano M, Cheng J, Li W, Moran K, Christians U, Finnegan C, Mills CD, Sutherland DE, Bansal-Pakala P, Murtaugh MP, Kirchhof N, Schuurman HJ (2006) Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12: 301-303
79. Hecht G, Eventov-Friedman S, Rosen C, Shezen E, Tchorsh D, Aronovich A, Freud E, Golan H, El-Hasid R, Katchman H, Hering BJ, Zung A, Kra-Oz Z, Shaked-Mishan P, Yusim A, Shtabsky A, Idelevitch P, Tobar A, Harmelin A, Bachar-Lustig E, Reisner Y (2009) Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci USA 106: 8659-8664
80. Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, Penn R, Starr P, VanHorne C, Kott HS, Dempsey PK, Fischman AJ, Raineri R, Manhart C, Dinsmore J, Isacson O (2000) Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results. Cell Transplant 9:273-278
81. Badin RA, Padoan A, Vadori M, Boldrin M, De Benedictis GM, Fante F, Sgarabotto D, Jan C, Daguin V, Naveilhan P, Neveu I, Soullilou JP, Vanhove B, Plat M, Botté F, Venturi F, Denaro L, Seveso M, Manara R, Zampieri P, D'Avella D, Rubello D, Ancona E, Hantraye P, Cozzi E (2010) Porcine embryonic xenografts transgenic for CTLA4-Ig enable longterm Recovery in parkinsonian macaques. Am J Transplant 10(Suppl s4):208
82. Lynch RJ, Platt JL (2009) Escaping from rejection. Transplantation 88:1233-1236
83. Koch CA, Khalpey ZI, Platt JL (2004) Accommodation: Preventing injury in transplantation and disease. J Immunol 172: 5143-5148
84. Ildstad ST, Sachs DH (1984) Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168-170
85. Sharabi Y, Aksentijevich I, Sundt TM 3rd, Sachs DH, Sykes M (1990) Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 172:195-202
86. Yang YG, deGoma E, Ohdan H, Bracy JL, Xu Y, Iacomini J, Thall AD, Sykes M (1998) Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 187:1335-1342
87. Abe M, Qi J, Sykes M, Yang YG (2002) Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier. Blood 99:3823-3829
88. Murakami T, Cosimi AB, Kawai T (2009) Mixed chimerism to induce tolerance: Lessons learned from nonhuman primates. Transplant Rev (Orlando) 23:19-24
89. Barth RN, Yamamoto S, LaMattina JC, Kumagai N, Kitamura H, Vage fi PA, Awwad M, Colvin RB, Cooper DK, Sykes M, Sachs DH, Yamada K (2003) Xenogeneic thymokidney and thymic tissue transplantation in a pigto-baboon model: I evidence for pig-specific T-cell unresponsiveness. Transplantation 75: 1615-1624
90. Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, O'Malley P, Nobori S, Vage fi PA, Patience C, Fishman J, Cooper DK, Hawley RJ, Greenstein J, Schuurman HJ, Awwad M, Sykes M, Sachs DH (2005) Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3- galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11:32-34
91. Griesemer AD, Hirakata A, Shimizu A, Moran S, Tena A, Iwaki H, Ishikawa Y, Schule P, Arn JS, Robson SC, Fishman JA, Sykes M, Sachs DH, Yamada K (2009) Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 9:2669-2678
92. Muller YD, Golshayan D, Ehirchiou D, Wekerle T, Seebach JD, Buhler LH (2009) T regulatory cells in xenotransplantation. Xenotransplantation 16:121-128
93. Dons EM, Raimondi G, Cooper DK, Thomson AW (2010) Non-human primate regulatory T cells: Current biology and implications for transplantation. Transplantation 90:811-816
94. Porter CM, Bloom ET (2005) Human CD4+CD25+ regulatory T cells suppress antiporcine xenogeneic responses. Am J Transplant 5:2052-2057
95. http://www.tts.org/index.php?option=com-content&view=article&id= 51&Itemid=292
96. http://www.who.int/transplantation/xeno/en
97. http://www.humanxenotransplant.org
98. Sgroi A, Buhler LH, Morel P, Sykes M, Noel L (2010) International human xenotransplantation inventory. Transplantation 90:597-603